Adcock Ingram Holdings Limited

PINK:AIHLF USA Drug Manufacturers - Specialty & Generic
Market Cap
$359.57 Million
Market Cap Rank
#18881 Global
#6982 in USA
Share Price
$2.45
Change (1 day)
+0.00%
52-Week Range
$2.45 - $2.45
All Time High
$2.45
About

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products… Read more

Adcock Ingram Holdings Limited (AIHLF) - Total Assets

Latest total assets as of June 2025: $8.74 Billion USD

Based on the latest financial reports, Adcock Ingram Holdings Limited (AIHLF) holds total assets worth $8.74 Billion USD as of June 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Adcock Ingram Holdings Limited - Total Assets Trend (2005–2025)

This chart illustrates how Adcock Ingram Holdings Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Adcock Ingram Holdings Limited - Asset Composition Analysis

Current Asset Composition (June 2025)

Adcock Ingram Holdings Limited's total assets of $8.74 Billion consist of 60.0% current assets and 40.0% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 1.2%
Accounts Receivable $2.22 Billion 25.4%
Inventory $2.81 Billion 32.2%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $984.90 Million 11.3%
Goodwill $176.34 Million 2.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Adcock Ingram Holdings Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Adcock Ingram Holdings Limited's current assets represent 60.0% of total assets in 2025, a decrease from 63.8% in 2005.
  • Cash Position: Cash and equivalents constituted 1.2% of total assets in 2025, down from 11.2% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 0.0% in 2005.
  • Asset Diversification: The largest asset category is inventory at 32.2% of total assets.

Adcock Ingram Holdings Limited Competitors by Total Assets

Key competitors of Adcock Ingram Holdings Limited based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Adcock Ingram Holdings Limited - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.99 - 1.15

Strong asset utilization - Adcock Ingram Holdings Limited generates 1.12x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 3.02% - 11.01%

Solid ROA - For every $100 in assets, Adcock Ingram Holdings Limited generates $9.83 in net profit.

Adcock Ingram Holdings Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.06 1.93 1.76
Quick Ratio 0.95 0.93 0.89
Cash Ratio 0.00 0.00 0.00
Working Capital $2.70 Billion $ 2.36 Billion $ 1.67 Billion

Adcock Ingram Holdings Limited - Advanced Valuation Insights

This section examines the relationship between Adcock Ingram Holdings Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.52
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) 4.6%
Total Assets $8.74 Billion
Market Capitalization $85.61 Million USD

Valuation Analysis

Below Book Valuation: The market values Adcock Ingram Holdings Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Adcock Ingram Holdings Limited's assets grew by 4.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Adcock Ingram Holdings Limited (2005–2025)

The table below shows the annual total assets of Adcock Ingram Holdings Limited from 2005 to 2025.

Year Total Assets Change
2025-06-30 $8.74 Billion +4.56%
2024-06-30 $8.35 Billion +1.12%
2023-06-30 $8.26 Billion +4.73%
2022-06-30 $7.89 Billion +12.06%
2021-06-30 $7.04 Billion -1.97%
2020-06-30 $7.18 Billion +14.89%
2019-06-30 $6.25 Billion -0.32%
2018-06-30 $6.27 Billion +12.72%
2017-06-30 $5.56 Billion -0.60%
2016-06-30 $5.60 Billion +2.54%
2015-06-30 $5.46 Billion +0.96%
2014-06-30 $5.41 Billion -19.97%
2013-06-30 $6.75 Billion +31.22%
2012-06-30 $5.15 Billion -1.68%
2011-06-30 $5.24 Billion +10.05%
2010-06-30 $4.76 Billion +40.44%
2009-06-30 $3.39 Billion +24.87%
2008-06-30 $2.71 Billion +7.59%
2007-06-30 $2.52 Billion -21.01%
2006-06-30 $3.19 Billion +51.67%
2005-06-30 $2.10 Billion --